Hafnarfjordur
Iceland
46
2015-10-22
6
2016-12-06
These are the the leading inventors for applications assigned to ACTAVIS GROUP PTC EHF:
ACTAVIS GROUP PTC EHF based in Hafnarfjordur, IS has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Solid state forms of tapentadol salts
#2 | 2013-11-28NOVEL PROCESSES FOR PREPARING TRIAZOLO[4, 5-d]PYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF
#3 | 2013-06-27NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR
#4 | 2013-04-25HIGHLY PURE VARENICLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF SUBSTANTIALLY FREE OF METHYLVARENICLINE IMPURITY
#5 | 2013-04-18NOVEL PROCESS FOR PREPARING HIGHLY PURE TAPENTADOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#6 | 2013-04-18RESOLUTION METHODS FOR ISOLATING DESIRED ENANTIOMERS OF TAPENTADOL INTERMEDIATES AND USE THEREOF FOR THE PREPARATION OF TAPENTADOL
#7 | 2013-04-11 ✅ Patent 8,981,154 granted on 2015-03-17Solid state forms of tapentadol salts
#8 | 2013-03-21PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#9 | 2013-01-31 ✅ Patent 8,859,769 granted on 2014-10-14Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
#10 | 2012-10-25SOLID STATE FORMS OF RASAGILINE SALTS
#11 | 2012-04-26SOLID STATE FORMS OF PALIPERIDONE SALTS AND PROCESS FOR THE PREPARATION THEREOF
#12 | 2012-04-19AMORPHOUS VARENICLINE TARTRATE CO-PRECIPITATES
#13 | 2012-03-01PURIFICATION PROCESS FOR PREPARING HIGHLY PURE ARFORMOTEROL TARTRATE SUBSTANTIALLY FREE OF DESFORMYL IMPURITY
#14 | 2012-02-02HIGHLY PURE ELETRIPTAN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF SUBSTANTIALLY FREE OF ELETRIPTAN N-OXIDE IMPURITY
#15 | 2012-01-12HIGHLY PURE LAQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#16 | 2011-12-29HIGHLY PURE CINACALCET OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#17 | 2011-12-22PROCESSES FOR PREPARING SUBSTANTIALLY PURE ARFORMOTEROL AND ITS INTERMEDIATES
#18 | 2011-12-22PROCESSES FOR PREPARING HIGHLY PURE ROTIGOTINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#19 | 2011-12-08NOVEL SOLID STATE FORMS OF RANOLAZINE SALTS
#20 | 2011-10-06PROCESS FOR PREPARING PREGABALIN
#21 | 2011-09-15 ✅ Patent 8,314,235 granted on 2012-11-20Process for preparing varenicline, varenicline intermediates, pharmaceutically acceptable salts thereof
#22 | 2011-07-21UNSATURATED CINACALCET SALTS AND PROCESSES FOR PREPARING CINACALCET HYDROCHLORIDE
#23 | 2011-07-14SUBSTANTIALLY PURE DEFERASIROX AND PROCESSES FOR THE PREPARATION THEREOF
#24 | 2011-06-16Amorphous Coprecipitates of Atorvastatin Pharmaceutically Acceptable Salts
#25 | 2011-05-26SOLID STATE FORMS OF FESOTERODINE INTERMEDIATES
#26 | 2011-05-19RASAGILINE MESYLATE PARTICLES AND PROCESS FOR THE PREPARATION THEREOF
#27 | 2011-04-28SOLID STATE FORMS OF DEFERASIROX SALTS AND PROCESS FOR THE PREPARATION THEREOF
#28 | 2011-04-14NOVEL MANDELATE SALT OF FESOTERODINE
#29 | 2011-03-24 ✅ Patent 8,288,592 granted on 2012-10-16Solid state forms of tapentadol salts
#30 | 2011-01-27Substantially Pure and a Stable Crystalline Form of Bosentan
#31 | 2011-01-20AMORPHOUS ARFORMOTEROL L-(+)-TARTRATE
#32 | 2010-12-30SUBSTANTIALLY PURE IMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#33 | 2010-12-16Process for the Preparation of Risedronate Sodium
#34 | 2010-11-25Amorphous Fesoterodine Fumarate
#35 | 2010-11-11Novel Hemioxalate Salt of Eletriptan
#36 | 2010-11-04 ✅ Patent 8,101,597 granted on 2012-01-24Quetiapine salts and their polymorphs
#37 | 2010-10-14Novel Polymorph of Atorvastatin Calcium and Use Thereof for the Preparation of Amorphous Atorvastatin Calcium
#38 | 2010-08-12Novel Polymorphs of Darifenacin Free Base and its Hydrobromide Salt
#39 | 2010-08-05Repaglinide Substantially Free of Dimer Impurity
#40 | 2010-07-08PROCESS FOR THE PREPARATION OF ALFUZOSIN AND SALTS THEREOF
#41 | 2010-06-17STABLE ATORVASTATIN FORMULATIONS
#42 | 2010-04-29Lercanidipine Hydrochloride Polymorphs and an Improved Process for Preparation of 1,1,N-Trimethyl-N-(3,3-Diphenylpropyl)-2-Aminoethyl Acetoacetate
#43 | 2009-10-01Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity
#44 | 2009-10-01O-desmethylvenlafaxine Cocrystals
#45 | 2009-07-30Controlled-Release Tolterodine Compositions and Methods
#46 | 2009-03-05Paliperidone Polymorphs
Also check out Actavis Group PTC EHF's (Hafnarfjordur, Iceland) applicant profile with 1 patent applications submitted.
7416 ⎘